Global Immunoprotein Diagnostic Testing Market (2020 to 2027) – by Technology, Type and Application – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Immunoprotein Diagnostic Testing Market by Technology, Type and Application: Global Opportunity Analysis and Industry Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering.
The global immunoprotein diagnostic testing market was valued at $10,136.40 million in 2019 and is projected to reach $18,387.19 million by 2027, registering a CAGR of 6.6% from 2020 to 2027.
Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiovascular, oncology, infectious diseases, and others, as they display an abnormal increase in their concentration when in a diseased state.
The growth of the global immunoprotein diagnostic testing market is propelled by increase in incidence & prevalence of infectious and chronic diseases, rise in geriatric population, and growth in demand for early diagnostic services. In addition, technological advancements in immunodiagnostic instruments and introduction of novel automated systems are all set to augment the growth of immunoprotein diagnostic testing market during the forecast period. On the contrary, complex regulatory framework for immunoprotein diagnostic testing limits the growth of the market. Conversely, ongoing development in condition-specific assays & tests and the need for early diagnosis in the emerging economies across the world provide lucrative opportunities for the market growth.
The immunoprotein diagnostic testing market is segmented on the basis of type, application, technology, and region. Based on technology, the immunoprotein diagnostic testing market is classified into radioimmunoassay, immunoturbidity assay, immunoprotein electrophoresis, enzyme-linked immunosorbent assay, and others. Under the enzyme-linked immunosorbent assay, the market is further divided into chemiluminescence immunoassay, fluorescence immunoassay, and colorimetric immunoassay. Based on type, the market is categorized into C-reactive protein diagnostic test, complement system protein diagnostic test, pre-albumin diagnostic test, haptoglobin diagnostic test, immunoglobulin diagnostic test, free light chain diagnostic test, and others. Applications of immunoprotein diagnostic testing covered in the study include autoimmune disease testing, infectious disease testing, allergy testing, endocrine testing, oncology testing, toxicology testing, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Stakeholders
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
- A comprehensive analysis of the factors that drive and restrain the growth of the global immunoprotein diagnostic testing market is provided.
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
Market Dynamics
- Increasing Incidence of Chronic and Infectious Diseases
- Technological Advancements
- Stringent Regulations
- Lucrative Opportunities from Emerging Economies
- Development of Condition-Specific Assays and Tests
Companies Profiled
- Abbott Laboratories
- Abcam plc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Diasorin S. P. A
- Enzo Biochem, Inc.
- F. Hoffmann-La Roche AG (Roche Diagnostics)
- Ortho Clinical Diagnostics
- Siemens AG
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9171v1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
